Google Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? Google Inc trades at $349.2 (market cap $4.24T), while Relay Therapeutics Inc. Common Stock trades at $17.59 (market cap $3.82B). The key difference: Google Inc is far larger — about 1109.9× Relay Therapeutics Inc. Common Stock's market cap, and Google Inc pays a 0.26% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Google Inc for 137 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| GOOG | RLAY | |
|---|---|---|
Market Cap | $4.24T | $3.82B |
Volume | 13,937,902 | 4,332,079 |
Sector | Media | Health |
52-Week High | $399.06 | $20.75 |
52-Week Low | $237.49 | $6.03 |
Typical Hold Time | 137 Days | 0 Days |
Enterprise Value | $4.13T | $2.93B |
Dividend Yield | 0.26% | — |
Signals from Pluang's Aura AI — not financial advice
Alphabet (GOOG) trades at $347.37, up 0.81% with strong bullish technical signals. The company demonstrates exceptional fundamental strength with 2025 revenue of $402.84B and net income of $132.17B, maintaining robust profitability margins. Recent earnings beats and aggressive AI investments highlight growth momentum, though capital expenditure spikes have raised free cash flow concerns. Analyst consensus remains overwhelmingly positive with 87% buy ratings and a $435.24 price target.
Alphabet presents a compelling growth story with dominant market positioning and AI leadership, though investors face risks from regulatory scrutiny, intense competition, and significant capital expenditure requirements. The stock's current valuation appears reasonable relative to growth prospects, with technical indicators supporting near-term upside potential toward resistance levels around $350-352.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Read more on GOOG →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →